Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “CTOR”

756 pharma patents match "CTOR" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 756
Index total 30,257
Page 19 / 32

Quick answer

This filtered view shows 756 pharmaceutical patents matching "CTOR" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

756 results for “CTOR” · 30,257 patents in full index Clear search

  1. US 8778870

    Modified factor IX polypeptides and uses thereof

    Catalyst Biosciences, Inc. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  2. US 8772238

    Use of ixolaris, a tissue factor inhibitor, for the treatment of cancer

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted

  3. US 8765665

    Albumin-free factor VIII formulations

    UNIVERSITY OF CONNECTICUT · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted

  4. US 8765146

    Adenoviral vector-based malaria vaccines

    United States of America as represented by the Secretary of the Air Force · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted

  5. US 8754081

    Compositions and methods for inhibition of hepatocyte growth factor receptor c-Met signaling

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  6. US 8754044

    Neuroprotection by hepatic cells and hepatocyte secretory factors

    Northwestern University · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  7. US 8747845

    Methods of treatment by administering antibodies that bind colony stimulating factor 1 receptor (CSF1R)

    Five Prime Therapeutics, Inc. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  8. US 8747843

    Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as cardiac-derived myocardial depressant factor

    The Board of Regents of the University of Texas System · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  9. US 8735358

    Methods for treating cancer by regulation of tumor necrosis factor-alpha

    The Regents of the University of Colorado, a Body Corporate · Granted May 27, 2014 · Expires May 22, 2034

    granted

  10. US 8728458

    Combination anti-HIV vectors, targeting vectors, and methods of use

    The Regents of the University of California · Granted May 20, 2014 · Expires May 15, 2034

    granted

  11. US 8729053

    Nuclear factor kappa B pathway inhibitor composition and use of same

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 20, 2014 · Expires May 15, 2034

    granted

  12. US 8715645

    Viral vectors encoding apoptosis-inducing proteins and methods for making and using the same

    The Regents of the University of Colorado · Granted May 6, 2014 · Expires May 1, 2034

    granted

  13. US 8709774

    Sperm factor sequences

    University College Cardiff Consultants Limited · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  14. US 8703140

    Inhibition of factor B, the alternative complement pathway and methods related thereto

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  15. US 8697138

    Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders

    Aker Biomarine AS · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  16. US 8697853

    TAL effector-mediated DNA modification

    Regents of the University of Minnesota · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  17. US 8691195

    Peptide having activity of transforming growth factor and production method therefor

    CAREGEN CO., LTD. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  18. US 8685932

    Targeted transforming growth factor-beta-bound IgG for Treatment of Diseases

    OPTION PHARMACEUTICALS, LLC · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  19. US 8685403

    Insulin-like growth factor signaling and integrin

    The Regents of the University of California · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  20. US 8685722

    Bovine adeno-associated viral (BAAV) vector and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  21. US 8680056

    Antiproliferative factor and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  22. US 8680150

    Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors

    Ligand Pharmaceuticals Incorporated · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  23. US 8664193

    Compositions and methods for inhibiting expression of factor VII gene

    Alnylam Pharmaceuticals, Inc. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  24. US 8658778

    hTMC promoter and vectors for the tumor-selective and high-efficient expression of cancer therapeutic genes

    The Board of Regents of the University of Texas System · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.